Dementia in Latin America
Assessing the present and envisioning the future
Citation Manager Formats
Make Comment
See Comments

Article Information
- Received July 29, 2017
- Accepted in final form October 2, 2017
- First Published January 5, 2018.
Article Versions
- Previous version (January 5, 2018 - 12:45).
- You are viewing the most recent version of this article.
Author Disclosures
- Mario A. Parra, MD, PhD,
- Sandra Baez, PhD,
- Ricardo Allegri, MD, PhD,
- Ricardo Nitrini, PhD,
- Francisco Lopera, MD, PhD,
- Andrea Slachevsky, MD, PhD,
- Nilton Custodio, MD, PhD,
- David Lira, PhD,
- Olivier Piguet, PhD,
- Fiona Kumfor, PhD,
- David Huepe, PhD,
- Patricia Cogram, PhD,
- Thomas Bak, PhD,
- Facundo Manes, MD, PhD and
- Agustin Ibanez, PhD
- Mario A. Parra, MD, PhD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Sandra Baez, PhD,
NONE
NONE
NONE
Journal of Alzheimer's Disease, associate editor, 2016
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Ricardo Allegri, MD, PhD,
NONE
NONE
Novartis, Jannsen, Lundbeck, Ever neuropharma Educacional free.
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Ricardo Nitrini, PhD,
Advisory board meeting of Janssen-Cilag in 2012 Advisory meeting with Brazilian Nutricia board in 2013
NONE
Funding for travel to Alzheimer Association International Congress. Novartis 2012 and 2013
Editor - Dementia & Neuropsychologia 2007-present Area-Editor (Neurology) - Clinics 2016 - presnt Editorial Board member- Alzheimer's Disease and Associated Disordes - 2004-present Editorial Board member - Journal of Alzheimer Disease 2016- present
NONE
NONE
NONE
NONE
Speaker in a meeting sponsored by Novartis in 2012 peaker in a meeting sponsored by Danone (Nutricia) in 2013
NONE
I work in private clinic as clinical neurologist
NONE
FAPESP (Foundation for the support of research in the S?o Paulo State, Brazil) for epidemiology study on dementia in Brazil Conselho Nacional de Pesquisa (CNPq)
NONE
Federico Foundation
NONE
NONE
NONE
NONE
NONE
NONE
- Francisco Lopera, MD, PhD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
I am principal investigator in a GRANT "API COLOMBIA" with funds from GENENTECH, BANNER INSTITUTE AND NIH
NONE
BANNER INSTITUTE GENENTECH
COLCIENCIAS GRANT NIH
UNIVERSITY OF ANTIOQUIA (ACADEMIC ENTITY)
FIDELITY FOUNDATION
NONE
NONE
NONE
NONE
NONE
NONE
- Andrea Slachevsky, MD, PhD,
NONE
NONE
NONE
Associated Editor Journal of Alzheimer's Disease
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Nilton Custodio, MD, PhD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- David Lira, PhD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Olivier Piguet, PhD,
NONE
NONE
NONE
Frontiers in Dementia Research, Editorial Board, since 2011 Frontiers in Emotion Science, Editorial Board, since 2011 Behavioural Neurology, Editorial Board, since 2013 Brain Impairment, Editorial Board, since 2017
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
1) Australian Research Council, CE110001021, Centre of Excellence in Cognition and its Disorders, 2011-2018 2) National Health and Medical Research Council of Australia, APP1103258, Senior Research Fellowship 2016-2020
NONE
1) Velux Stiftung, Switzerland
NONE
NONE
NONE
NONE
NONE
NONE
- Fiona Kumfor, PhD,
NONE
NONE
NONE
(1) Journal of Alzheimer's Disease, Associate Editor, 3 years, (2) Frontiers in Aging Neuroscience, Review Editor, 2 years
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
(1) National Health and Medical Research Council (NHMRC)- Australian Research Council Dementia Research Development Fellowship, APP1097026, Fellowship recipient, 2016-2019, (2) NHMRC Project Grant APP1121791
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- David Huepe, PhD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Patricia Cogram, PhD,
NONE
NONE
NONE
Frontiers Ageing Neuroscience, editor, 2 years
Granted: Lawrence Irwin GLASS, Michael John Bickerdike, Michael Frederick Snape, Cogram Patricia. Treatment of autism spectrum disorders using glycyl-l-2-methylprolyl-l-glutamic acid, USA, 072049, 72049. International Application: PCT/US2013/072049 Lawrence Irwin GLASS, Michael John Bickerdike, Michael Frederick Snape, Cogram Patricia. Neuroprotective bicyclic compounds and methods for their use in treating autism spectrum disorders and neurodevelopmental disorders. Patent number: WO 2015013397 File and sold - to Fraunhofer-Gesellschaft, Germany-: Patricia Cogram, Robert Deacon, Wolfgang Schuch. Method for Alzheimer's disease drug screening and biomarker evaluation. International Application: PCT/IB2014/063047 Patricia Cogram, Robert Deacon, Wolfgang Schuch. Method for Alzheimer's disease drug screening and biomarker evaluation. International Application: PCT/IB2014/062497.
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
Institute of Ecology and Biodiversity, Science Faculty, University of Chile, Chile
Fragile X Foundation, USA. This entity awards do not have a number
NONE
NONE
NONE
NONE
NONE
NONE
- Thomas Bak, PhD,
NONE
NONE
NONE
Associate Editor of ALS FTD Journal (since January 2013). Member of Editorial Board of Behavioural Neurology (since 2008) and Aphasiology (since 2012). No compensations receieved
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Facundo Manes, MD, PhD and
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Agustin Ibanez, PhD
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
CONICET, Principal Investigator, 2011 CONICYT/FONDECYT Regular Principal Investigator 1170010 FONCyT-PICT 2012-0412, Principal Investigator FONCyT-PICT 2012-1309, Principal Investigator FONDAP 15150012, Associated researcher INECO Foundation, Principal Investigator Inter-American Development Bank (IDB) Principal Investigator
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- From the School of Life Sciences (M.A.P.), Psychology, University Heriot-Watt; Human Cognitive Neuroscience (M.A.P.), Psychology, Edinburgh University; Alzheimer's Scotland Dementia Research Centre and Scottish Dementia Clinical Research Network (M.A.P.), Edinburgh; Centre for Cognitive Ageing and Cognitive Epidemiology (M.A.P., T.B.) and Department of Psychology, School of Philosophy, Psychology and Language Sciences (P.C., T.B.), University of Edinburgh, UK; Universidad Autónoma del Caribe (M.A.P., A.I.), Barranquilla, Colombia; Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET) (S.B., F.M., A.I.); Institute of Translational and Cognitive Neuroscience (INCYT) (S.B., F.M., A.I.), INECO Foundation, Favaloro University, Buenos Aires, Argentina; Departamento de Psicología (S.B.) Universidad de los Andes, Bogotá, Colombia; Department of Cognitive Neurology and Neuropsychology (R.A.), Instituto de Investigaciones Neurológicas “Raúl Carrea” (FLENI) (R.A.), Buenos Aires, Argentina; Universidad de la Costa (CUC) (R.A.), Barranquilla, Colombia; Department of Neurology (R.N.), University of São Paulo Medical School, Brazil; Group of Neuroscience (F.L.), University of Antioquia, Medellín, Colombia; Geroscience Center for Brain Health and Metabolism (A.S.); Physiopathology Department, ICBM, and East Neuroscience Department, Faculty of Medicine (A.S.), and Center for Advanced Research in Education (CIAE) (A.S.), University of Chile; Cognitive Neurology and Dementia, Neurology Department (A.S.), Hospital del Salvador; Neurology Department, Clínica Alemana (A.S.), Santiago, Chile; Research Unit, Peruvian Institute of Neurosciences (N.C., D.L.) and Unit Cognitive Impairment and Dementia Prevention (N.C., D.L.), Lima, Peru; Brain and Mind Centre & School of Psychology (O.P., F.K.), Faculty of Science, University of Sydney; ARC Centre of Excellence in Cognition and its Disorders (O.P., F.K., F.M., A.I.), Sydney, Australia; Fraunhofer Chile (O.P., P.C.), Santiago; and Center for Social and Cognitive Neuroscience (CSCN), School of Psychology (D.H., A.I.), Universidad Adolfo Ibáñez, Santiago, Chile.
- Correspondence
Dr. Ibanez aibanez{at}ineco.org.ar
Article usage
Cited By...
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
- Article
- Abstract
- Glossary
- The goal of this work
- Timely diagnosis
- Current epidemiologic landscape
- Health care practitioners responsible for the diagnosis of dementia
- Procedures followed to make a diagnosis
- Therapeutic approaches
- Local regulations
- Currently available treatments
- Potential avenues for collaboration
- Promoting collaboration forums and large-scale computational capacity
- Capitalizing on unique populations
- Toward a regional network for translation research
- Discussion
- Author contributions
- Study funding
- Disclosure
- Footnotes
- References
- Figures & Data
- Info & Disclosures
Dr. Nicole Sur and Dr. Mausaminben Hathidara
► Watch
Related Articles
- No related articles found.
Topics Discussed
Alert Me
Recommended articles
-
Global Perspectives
The first steps of clinical neurology in South AmericaRicardo Francisco Allegri, Leonardo Bartoloni et al.Neurology, April 01, 2013 -
Article
Dementia and lower blood pressure in Latin America, India, and ChinaA 10/66 cross-cohort studyEmiliano Albanese, Flavia L. Lombardo, Martin J. Prince et al.Neurology, June 14, 2013 -
Departments
International NewsletterAntonio Culebras et al.Neurology, December 22, 2003 -
Global Perspectives
Neurology outreach clinic for Huntington disease in PeruLessons for neurodegenerative diseasesAnastasia Vishnevetsky, Maryenela Illanes-Manrique, Miguel Inca-Martinez et al.Neurology, July 06, 2018